An Investigational Immuno-therapy Study for Safety of Nivolumab in Combination With Ipilimumab to Treat Advanced Cancers

Part of paid clinical trials in Birmingham, Alabama.

Sponsor
Bristol-Myers Squibb
Study ID
NCT02869789
Phase
PHASE4
Status
Completed

Conditions

Eligibility Criteria

Sex
ALL
Age
18 Years - N/A
Healthy Volunteers
Not accepted

Interventions

Study Details

A study to evaluate the safety of Nivolumab given in combination with Ipilimumab in patients with advanced cancers. The initial group will enroll patients with newly diagnosed Stage 4 or non-small cell lung cancer that has come back.

Key Dates

Start date
Oct 5, 2016
Status verified
Jun 2023
Primary completion
May 13, 2022
Completion
May 13, 2022

Study Design

Enrollment
1,041 participants (actual)
Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT

Arms

  • Experimental: Nivolumab in combination with Ipilimumab
    Specified dose on specified days

Primary Outcome Measure

Number of Participants With High Grade (Grade 3-4 and Grade 5) Drug-Related Select Adverse Events (AEs) [ Time Frame: From first dose to 30 days post last dose (Up to approximately 27 months) ]

Locations (61)

FacilityCityStateZIPSite coordinators
Local Institution - 0121BirminghamAlabama35205-
Local Institution - 0148PhoenixArizona85016-
Local Institution - 0085TucsonArizona85704-
Local Institution - 0164Little RockArkansas72205-
Local Institution - 0146BakersfieldCalifornia93309-
Marin Cancer Care, IncGreenbraeCalifornia94904-
Local Institution - 0115Los AngelesCalifornia90095-
Los Angeles Hematology/Oncology Medical GroupLos AngelesCalifornia90017-
Torrance Health AssociationRedondo BeachCalifornia90277-
Va San Diego Healthcare SystemSan DiegoCalifornia92161-
Local Institution - 0143San Luis ObispoCalifornia93401-
Local Institution - 0144Santa MariaCalifornia93454-
Gene Upshaw Memorial Tahoe Forest Cancer CenterTruckeeCalifornia96161-
Local Institution - 0161WhittierCalifornia90603-
Local Institution - 0083DenverColorado80218-
Local Institution - 0141Grand JunctionColorado81501-
Cancer Specialists of North FLJacksonvilleFlorida32207-
Local Institution - 0082OcalaFlorida34474-
Local Institution - 0147Pembroke PinesFlorida33028-
Local Institution - 0163AthensGeorgia30607-
Local Institution - 0002AtlantaGeorgia30322-
Local Institution - 0166AtlantaGeorgia30342-
Local Institution - 0088NilesIllinois60714-
Local Institution - 0108WichitaKansas67214-
Kentucky One Health St. Joseph East Cancer CenterLexingtonKentucky40509-
Local Institution - 0091ColumbiaMaryland21044-
Local Institution - 0089EdinaMinnesota55435-2150-
Jackson Oncology Associates, PllcJacksonMississippi39202-
Local Institution - 0077Grand IslandNebraska68803-
Local Institution - 0087Las VegasNevada89148-
Local Institution - 0170RenoNevada89511-
Local Institution - 0156BellevilleNew Jersey07109-
Summit Medical GroupFlorham ParkNew Jersey07932-
Local Institution - 0142LivingstonNew Jersey07039-
Local Institution - 0167The BronxNew York10461-
Local Institution - 0004DurhamNorth Carolina27710-
Local Institution - 0012Winston-SalemNorth Carolina27157-
Local Institution - 0100CincinnatiOhio45242-
Local Institution - 0134ClevelandOhio44109-
Local Institution - 0172CorvallisOregon97330-
Local Institution - 0096EugeneOregon97401-
Local Institution - 0176PortlandOregon97239-
Local Institution - 0139AllentownPennsylvania18103-
Allegheny Health NetworkPittsburghPennsylvania15224-
Local Institution - 0159PittsburghPennsylvania15232-
Local Institution - 0001SayrePennsylvania18840-
Local Institution - 0123CharlestonSouth Carolina29414-
Local Institution - 0066ChattanoogaTennessee37404-
Local Institution - 0067NashvilleTennessee37203-
Local Institution - 0090AustinTexas78745-
Local Institution - 0149DallasTexas75231-
Texas Oncology, P.A.DallasTexas75230-
Local Institution - 0094Fort WorthTexas76104-
Local Institution - 0093LongviewTexas75601-
Local Institution - 0098PlanoTexas75075-7787-
Local Institution - 0086WacoTexas76712-
Local Institution - 0097FairfaxVirginia22031-
Local Institution - 0044RichmondVirginia23230-
Providence Regional Cancer PartnershipEverettWashington98201-
Local Institution - 0174RentonWashington98055-
Local Institution - 0173SpokaneWashington99208-

Find similar trials in Birmingham, AL

By condition
Lung cancer
By specialty
OncologyLung oncologyLung disease
By research site
Local Institution - 0121· Birmingham, ALLocal Institution - 0148· Phoenix, AZLocal Institution - 0085· Tucson, AZLocal Institution - 0164· Little Rock, ARLocal Institution - 0146· Bakersfield, CAMarin Cancer Care, Inc· Greenbrae, CA

Related Studies